UCLA Biodesign Fireside Chat Monthly Series:
Corporate Insights – A Leading Biopharmaceutical Company’s Lens into Digital Health, Investments & Innovation
Tuesday, 12/14/2021, 5:00 PM – 6:00 PM PT
Join Dr. Debbie Lin as she sits down for a Fireside Chat with UCLA Biodesign’s Medtech and Digital Health Innovation Hub, AILA, and BioscienceLA to discuss corporate innovation, board management, how she thinks about investment decisions, trends in digital health, and shares her experiences across the biopharmaceutical landscape during her exceptional 20 plus years of leadership.
About the Speaker:
Dr. Debbie Lin is Executive Director at Boehringer Ingelheim Venture Fund in the US and started and leads the Fund’s North American investment efforts in Digital Healthcare. She led the investments for and has Board Directorship roles at Wellth Inc. (New York, NY) and Bodyport Inc. (San Francisco, CA). She joined Boehringer Ingelheim Pharmaceuticals in 2008. Within Boehringer Ingelheim Pharma, she worked across various regions and divisions in both the USA and at the Corporate Headquarters in Germany. Dr. Lin received her doctorate in Pharmacogenomics and Bioinformatics from UCSF; she also has a Masters in Engineering from Stanford University and a Masters in Public Policy from UCLA.
To register, click here: https://uclahs.zoom.us/webinar/register/WN_l1KC7xEdQ0Ocop9sFQEYnw